Data / Research funding / Minnesota / Emmyon, Inc.
Emmyon, Inc.: 3 NIH awards ($3.8M), fiscal years 2021 to 2026
Emmyon, Inc. in Rochester, MN is funded under 3 NIH awards ($3.8M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- M8CMYGLPB5H7
- State
- Minnesota
Awards
3 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|
| Development of novel therapeutics for cancer cachexia | NIH | National Cancer Institute | 2023 to 2024 | $1,987,656 | April 1, 2023 | March 31, 2026 | EBERT, SCOTT MATTHEW | reporter.nih.gov |
| Development of novel therapeutics for obesity and type 2 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $1,021,719 | August 1, 2025 | July 31, 2027 | EBERT, SCOTT MATTHEW | reporter.nih.gov |
| Discovery of Novel Pharmaceutical Agents for Skeletal Muscle Atrophy | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $745,404 | April 1, 2016 | August 31, 2023 | EBERT, SCOTT MATTHEW | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|
| 2025 | 1 | $1,021,719 | 0 | $0 |
| 2024 | 1 | $997,245 | 0 | $0 |
| 2023 | 1 | $990,411 | 0 | $0 |
| 2021 | 1 | $745,404 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|
| Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required) | PAR-24-279 | NIH | 93.846 | November 2, 2026 | Not listed | Same assistance listing 93.846 as 1 award here |
| Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) | PAR-24-280 | NIH | 93.846 | November 2, 2026 | Not listed | Same assistance listing 93.846 as 1 award here |
| NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed) | PAR-27-089 | NIH | 93.395 | November 2, 2026 | Not listed | Same assistance listing 93.395 as 1 award here |
| Limited Competition for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Clinical Centers (U01 Clinical Trial Required) | RFA-DK-27-125 | NIH | 93.847 | November 6, 2026 | Not listed | Same assistance listing 93.847 as 1 award here |
| Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed) | RFA-DK-27-112 | NIH | 93.847 | November 9, 2026 | Not listed | Same assistance listing 93.847 as 1 award here |
| Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required) | RFA-DK-27-139 | NIH | 93.847 | November 9, 2026 | Not listed | Same assistance listing 93.847 as 1 award here |
| Precision Approaches in Radiation Synthetic Combinations (PAIRS, RP1 Clinical Trial Optional) | PAR-26-152 | NIH | 93.395 | November 11, 2026 | Not listed | Same assistance listing 93.395 as 1 award here |
| Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required) | RFA-DK-27-122 | NIH | 93.847 | November 17, 2026 | Not listed | Same assistance listing 93.847 as 1 award here |
| NCI Research Specialist Award for Core and Laboratory-based Scientists (R50 Clinical Trial Not Allowed) | PAR-27-088 | NIH | 93.395 | November 20, 2026 | Not listed | Same assistance listing 93.395 as 1 award here |
| HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional) | RFA-AT-25-003 | NIH | 93.846 | November 23, 2026 | $375,000 | Same assistance listing 93.846 as 1 award here |
| Restoring Joint Health and Function to Reduce Pain (RE-JOIN) 2.0 | RFA-AR-26-006 | NIH | 93.846 | December 1, 2026 | Not listed | Same assistance listing 93.846 as 1 award here |
| NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed) | RFA-OD-24-011 | NIH | 93.846 | December 4, 2026 | Not listed | Same assistance listing 93.846 as 1 award here |
| Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional) | PAR-27-039 | NIH | 93.846 | January 5, 2027 | Not listed | Same assistance listing 93.846 as 1 award here |
| Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional) | PAR-27-040 | NIH | 93.846 | January 5, 2027 | Not listed | Same assistance listing 93.846 as 1 award here |
| Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) | PAR-24-214 | NIH | 93.395 | January 7, 2027 | $375,000 | Same assistance listing 93.395 as 1 award here |
| Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) | PAR-25-079 | NIH | 93.395 | January 7, 2027 | $500,000 | Same assistance listing 93.395 as 1 award here |
| National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) | PAR-25-081 | NIH | 93.395 | January 7, 2027 | $499,999 | Same assistance listing 93.395 as 1 award here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.846 | January 7, 2027 | Not listed | Same assistance listing 93.846 as 1 award here |
| Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required) | RFA-CA-27-005 | NIH | 93.395 | January 11, 2027 | $700,000 | Same assistance listing 93.395 as 1 award here |
| HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed) | RFA-NS-25-023 | NIH | 93.846 | January 15, 2027 | $350,000 | Same assistance listing 93.846 as 1 award here |
Topics of its NIH awards
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.